Cargando…
Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
Peptidomimetics play a fundamental role in drug design due to their preferential properties regarding natural peptides. In particular, compounds possessing nitrogen-containing heterocycles have been intensively studied in recent years. The triazolyl moiety incorporation decreases the molecule suscep...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172596/ https://www.ncbi.nlm.nih.gov/pubmed/34095086 http://dx.doi.org/10.3389/fchem.2021.674705 |
_version_ | 1783702563075391488 |
---|---|
author | Staśkiewicz, Agnieszka Ledwoń, Patrycja Rovero, Paolo Papini, Anna Maria Latajka, Rafal |
author_facet | Staśkiewicz, Agnieszka Ledwoń, Patrycja Rovero, Paolo Papini, Anna Maria Latajka, Rafal |
author_sort | Staśkiewicz, Agnieszka |
collection | PubMed |
description | Peptidomimetics play a fundamental role in drug design due to their preferential properties regarding natural peptides. In particular, compounds possessing nitrogen-containing heterocycles have been intensively studied in recent years. The triazolyl moiety incorporation decreases the molecule susceptibility to enzymatic degradation, reduction, hydrolysis, and oxidation. In fact, peptides containing triazole rings are a typical example of peptidomimetics. They have all the advantages over classic peptides. Both efficient synthetic methods and biological activity make these systems an interesting and promising object of research. Peptide triazole derivatives display a diversity of biological properties and can be obtained via numerous synthetic strategies. In this review, we have highlighted the importance of the triazole-modified peptidomimetics in the field of drug design. We present an overview on new achievements in triazolyl-containing peptidomimetics synthesis and their biological activity as inhibitors of enzymes or against cancer, viruses, bacteria, or fungi. The relevance of above-mentioned compounds was confirmed by their comparison with unmodified peptides. |
format | Online Article Text |
id | pubmed-8172596 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81725962021-06-04 Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development Staśkiewicz, Agnieszka Ledwoń, Patrycja Rovero, Paolo Papini, Anna Maria Latajka, Rafal Front Chem Chemistry Peptidomimetics play a fundamental role in drug design due to their preferential properties regarding natural peptides. In particular, compounds possessing nitrogen-containing heterocycles have been intensively studied in recent years. The triazolyl moiety incorporation decreases the molecule susceptibility to enzymatic degradation, reduction, hydrolysis, and oxidation. In fact, peptides containing triazole rings are a typical example of peptidomimetics. They have all the advantages over classic peptides. Both efficient synthetic methods and biological activity make these systems an interesting and promising object of research. Peptide triazole derivatives display a diversity of biological properties and can be obtained via numerous synthetic strategies. In this review, we have highlighted the importance of the triazole-modified peptidomimetics in the field of drug design. We present an overview on new achievements in triazolyl-containing peptidomimetics synthesis and their biological activity as inhibitors of enzymes or against cancer, viruses, bacteria, or fungi. The relevance of above-mentioned compounds was confirmed by their comparison with unmodified peptides. Frontiers Media S.A. 2021-05-20 /pmc/articles/PMC8172596/ /pubmed/34095086 http://dx.doi.org/10.3389/fchem.2021.674705 Text en Copyright © 2021 Staśkiewicz, Ledwoń, Rovero, Papini and Latajka. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Chemistry Staśkiewicz, Agnieszka Ledwoń, Patrycja Rovero, Paolo Papini, Anna Maria Latajka, Rafal Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development |
title | Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development |
title_full | Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development |
title_fullStr | Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development |
title_full_unstemmed | Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development |
title_short | Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development |
title_sort | triazole-modified peptidomimetics: an opportunity for drug discovery and development |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172596/ https://www.ncbi.nlm.nih.gov/pubmed/34095086 http://dx.doi.org/10.3389/fchem.2021.674705 |
work_keys_str_mv | AT staskiewiczagnieszka triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment AT ledwonpatrycja triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment AT roveropaolo triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment AT papiniannamaria triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment AT latajkarafal triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment |